Join
Live feed
·
INSIDERFilingvia Quantisnow
Crescent Biopharma Inc. logo

Director Fairmount Funds Management Llc bought $12,375,025 worth of Ordinary Shares (853,450 units at $14.50) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CBIO· Crescent Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CBIO (Crescent Biopharma Inc.) and more on Quantisnow.